Jonathan Mark Sutton
33Patents
4h-index
52Co-inventors
66Inventor score
Filing activity: Jan 29, 2004 → Nov 16, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7326732B2 | EP2 receptor agonists | Chemistry; Metallurgy | 9 | Expired |
| US7803841B2 | EP2 receptor agonists | Chemistry; Metallurgy | 6 | Active |
| US7196089B2 | EP4 receptor antagonists | Chemistry; Metallurgy | 5 | Expired |
| US7417068B2 | EP4 receptor antagonists | Human Necessities | 5 | Expired |
| US10023558B2 | Compounds | Chemistry; Metallurgy | 4 | Active |
| US8691826B2 | Compounds | Human Necessities | 4 | Active |
| US9409870B2 | Compounds | Chemistry; Metallurgy | 4 | Active |
| US7569602B2 | Furan derivatives as EP4 receptor antagonists | Human Necessities | 4 | Expired |
| US9802919B1 | Compounds | Chemistry; Metallurgy | 4 | Active |
| US8080567B2 | EP2 receptor agonists | Chemistry; Metallurgy | 2 | Active |
| US7507754B2 | EP4 receptor antagonists | Chemistry; Metallurgy | 2 | Active |
| US7662839B2 | EP2 receptor agonists | Chemistry; Metallurgy | 2 | Active |
| US10844067B2 | Heterocyclic compounds as RET kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US7528157B2 | EP4 receptor antagonists | Chemistry; Metallurgy | 2 | Active |
| US11820751B2 | Urolithin derivatives and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US9023855B2 | Compounds | Human Necessities | 2 | Active |
| US11352361B2 | Compounds useful as RET inhibitors | Human Necessities | 1 | Active |
| US10954241B2 | Heterocyclic compounds as ret kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11000511B2 | Chemical compounds as antibiotics | Chemistry; Metallurgy | 1 | Active |
| US10172830B2 | Pyrazolone compounds having human neutrophil elastase inhibitory properties | Chemistry; Metallurgy | 0 | Active |
| US11680068B2 | Compounds useful as RET inhibitors | Human Necessities | 0 | Active |
| US9365577B2 | Pyrimidinone compounds as human neutrophil elastase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11661423B2 | Heterocyclic compounds as RET kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9199984B2 | Inhibition of enzymes | Human Necessities | 0 | Active |
| US9487528B2 | Compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.